Skip to content
OpenCapital
Get started

D-Wave Quantum QBTS Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

IonQ logo
IonQIONQ
——

Other financials

Income statement

See full
Revenue$2.9M-80.9%
Gross profit$1.8M-86.9%
Operating income-$54.7M-385%
Net income-$18.4M-239%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$338.2M+11.1%
Total debt$46.7M+22.5%
Total equity$1.1B+442%
Total assets$1.2B+268%

Cash flow

See full
Operating cash flow-$45.0M-133%
CapEx$1.1M+147%
Free cash flow-$46.0M-134%

Valuation

See full
Market cap$9.15B+141%
Enterprise value$8.85B+159%
P/S735×+557×

Profitability

See full
Gross margin66.3%-17.0pp
Operating margin-1,155.6%-1,938pp
Net margin-2,957.2%-4,019pp
FCF margin-821%-1,451pp

Returns & leverage

See full
Return on equity-55.3%—
Debt / equity0×-0.1×
Current ratio21.4×+0.7×

Where this comes from

Reported directly by D-Wave Quantum in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: D-Wave Quantum’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about D-Wave Quantum's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is D-Wave Quantum's share based compensation arrangement by share based payment award options exercisable number?
D-Wave Quantum (QBTS) reported share based compensation arrangement by share based payment award options exercisable number of $2.99M in Q1 2026.
How has D-Wave Quantum's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
D-Wave Quantum's share based compensation arrangement by share based payment award options exercisable number decreased by 68.7% year-over-year, from $9.56M to $2.99M.